Cervical Cancer Global Clinical Trials Review, H2, 2013

NEW YORK, Dec. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cervical Cancer Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0611560/Cervical-Cancer-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Cervical Cancer Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Cervical Cancer Global Clinical Trials Review, H2, 2013" provides data on the Cervical Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cervical Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Cervical Cancer 23

Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Merck & Co., Inc. 42
Clinical Trial Overview of Merck & Co., Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Eli Lilly and Company 46
Clinical Trial Overview of Eli Lilly and Company 46
ISA Pharmaceuticals B.V. 47
Clinical Trial Overview of ISA Pharmaceuticals B.V. 47
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48

Clinical Trial Overview of Top Institutes / Government 49
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
Gynecologic Oncology Group 58
Clinical Trial Overview of Gynecologic Oncology Group 58
The University of Texas M. D. Anderson Cancer Center 62
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 62
National Taiwan University Hospital 65
Clinical Trial Overview of National Taiwan University Hospital 65
University Health Network 66
Clinical Trial Overview of University Health Network 66
Tata Memorial Hospital 67
Clinical Trial Overview of Tata Memorial Hospital 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
Case Comprehensive Cancer Center 69
Clinical Trial Overview of Case Comprehensive Cancer Center 69
Radiation Therapy Oncology Group 70
Clinical Trial Overview of Radiation Therapy Oncology Group 70
Dana-Farber Cancer Institute, Inc. 71
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 71

Five Key Clinical Profiles 72
Appendix 113
Abbreviations 113
Definitions 113
Research Methodology 114
Secondary Research 114
About GlobalData 115
Contact Us 115
Disclaimer 115
Source 116

List of Tables

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Cervical Cancer Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Cervical Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 16
Cervical Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Cervical Cancer Therapeutics Clinical Trials, E7 Countries, 2013* 18
Cervical Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Cervical Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Cervical Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Cervical Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Cervical Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 42

Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 44
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 45
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 46
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ISA Pharmaceuticals B.V., 2013* 47
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 48
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 49
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2013* 58
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 62
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 65
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013* 66
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2013* 67
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 68
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013* 69
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2013* 70
Cervical Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2013* 71

List of Figures

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14

Cervical Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Cervical Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Cervical Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Cervical Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Cervical Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Cervical Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Cervical Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 114

To order this report: Cervical Cancer Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0611560/Cervical-Cancer-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker